GlucoBeam. Non-invasive glucose monitor
Diabetes is affecting an increasing number of individuals. Recent estimates suggest that 415 million people worldwide suffer from diabetes and the number is predicted to increase to 642 million by 2040. In the US diabetes and pre-diabetes affect over 100 million people, costing more than $325 billion each year. Self-monitoring of blood glucose is now even more critical for effective diabetes management.
Our goal at RSP Systems A/S is to set a new standard of care in diabetes management by developing the GlucoBeam, a non-invasive blood glucose monitoring system for people with diabetes who need to measure their glucose levels 4-6 times a day.1
1 Lundsgaard-Nielsen SM et al. PloS one. 2018; 13: e0197134
Find our RSP Systems Publications here
